Results 151 to 160 of about 4,822 (160)
Some of the next articles are maybe not open access.
Managing Patients with Vulvovaginal Candidiasis
The Nurse Practitioner, 1998Epidemiologic studies have demonstrated a continuing increase in the prevalence of vulvovaginal candidiasis. Although in the past most of these infections were caused by Candida albicans, an increasing percentage are caused by non-albicans Candida species that are less sensitive to the most frequently used antifungal agents.
openaire +3 more sources
Pathogenesis and Epidemiology of Vulvovaginal Candidiasis
Annals of the New York Academy of Sciences, 1988In contrast to women with infrequent episodes of candidal vaginitis, women with chronic and recurrent candidal vaginitis do not have recognizable precipitating or causal factors. Analysis of vaginal yeast isolated from women with recurrent candidal vaginitis, although revealing a higher percentage of non-albicans Candida sp., indicates that resistance ...
openaire +3 more sources
Clinical evidence, 2005
Vulvovaginal candidiasis is estimated to be the second most common cause of vaginitis after bacterial vaginosis. Candida albicans accounts for 85% to 90% of cases.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of drug treatments for acute vulvovaginal candidiasis in non-pregnant symptomatic ...
openaire +5 more sources
Vulvovaginal candidiasis is estimated to be the second most common cause of vaginitis after bacterial vaginosis. Candida albicans accounts for 85% to 90% of cases.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of drug treatments for acute vulvovaginal candidiasis in non-pregnant symptomatic ...
openaire +5 more sources
An epidemiological survey of vulvovaginal candidiasis in Italy
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2003Eight Italian hospital or University gynecology clinics participated in a prospective survey of patients with culture-confirmed symptomatic vulvovaginal candidiasis (VVC) (October 1999 to March 2001). Of 1138 patients recruited in the study, 931 were evaluable. A recent history of VVC was documented in 43.5% patients (358/823) with a mean number of 2.9+
CORSELLO S +31 more
openaire +5 more sources
Classification and pathogenesis of vulvovaginal candidiasis
American Journal of Obstetrics and Gynecology, 1985Although candidiasis of the female genital tract is one of the most common of the vaginitides, it is a poorly understood disease entity. Vulvovaginal candidiasis is a monoetiologic disease, but the pathways by which pathogenic expression is attained are sufficiently divergent to constitute a classification schema that influences therapy.
openaire +2 more sources
Pathogenesis of recurrent vulvovaginal candidiasis
Current Infectious Disease Reports, 2002Recurrent vulvovaginal candidiasis (RVVC) is by no means uncommon and is a source of considerable physical suffering, in addition to serving as a major therapeutic challenge. The syndrome is multifactorial in etiology, hence management strategies must recognize the complex etiologic pathways. Considerable progress has been made in identifying secondary
openaire +2 more sources
The impact of oral contraception on vulvovaginal candidiasis
Contraception, 1995To evaluate risk factors related to sociodemographic and clinical variables, oral contraception and sexual behavior of women with recurrent vulvovaginal candidiasis, we conducted a case-control study comparing 153 patients with recurrent vulvovaginal candidiasis with both asymptomatic women with negative vaginal cultures and patients with nonrecurrent ...
SPINILLO, ARSENIO +5 more
openaire +4 more sources
Three-day treatment of vulvovaginal candidiasis
American Journal of Obstetrics and Gynecology, 1988Butoconazole nitrate, a newer imidazole, is effective for the treatment of vulvovaginal candidiasis when administered as a vaginal cream. The microbiologic and clinical cure rates achieved with a 3-day course of butoconazole 2% cream have been comparable with those obtained with a 6-day course of miconazole nitrate 2% cream or a 3-day course of ...
openaire +4 more sources
Managing Recurrent Vulvovaginal Candidiasis
Journal of Women's HealthSandhya, Nagarakanti +2 more
openaire +2 more sources